COVID-19, Inflammatory Heart Disease, and Vaccination in the Athlete and Highly Active Person: An Update and Further Considerations
Can J Cardiol
.
2022 Oct;38(10):1580-1583.
doi: 10.1016/j.cjca.2022.05.019.
Epub 2022 May 25.
Authors
Nathaniel Moulson
1
,
Kim A Connelly
2
,
Paul Dorian
2
,
Anne Fournier
3
,
Jack M Goodman
2
,
Nicholas Grubic
4
,
Saul Isserow
1
,
Amer M Johri
5
,
François Philippon
6
,
Andrew Pipe
7
,
Paul Poirier
6
,
Ryan Quinn
8
,
Taryn Taylor
9
,
Jane Thornton
10
,
Mike Wilkinson
11
,
James McKinney
12
Affiliations
1
Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada.
2
Division of Cardiology, Li Ka Shing Knowledge Institute of St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
3
Centre Hospitalier Universitaire Sainte-Justine, University of Montréal, Montréal, Québec, Canada.
4
Department of Public Health Sciences, Queen's University, Kingston, Ontario, Canada.
5
Division of Cardiology, Queen's University, Kingston, Ontario, Canada.
6
Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec City, Québec, Canada.
7
University of Ottawa Heart Institute, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
8
Division of Cardiology, McMaster University, Hamilton, Ontario, Canada.
9
Department of Sports Medicine, Carleton Sport Medicine Clinic, Ottawa, Ontario, Canada.
10
Department of Sports Medicine, Western University, London, Ontario, Canada.
11
Department of Sports Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
12
Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: james.mckinney@ubc.ca.
PMID:
35643383
PMCID:
PMC9132493
DOI:
10.1016/j.cjca.2022.05.019
No abstract available
MeSH terms
Athletes
COVID-19* / prevention & control
Heart
Heart Diseases*
Humans
Vaccination